Luis E Fayad

Associate Professor

  • 9706 Citations
  • 54 h-Index
19962019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 14 Similar Profiles
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Non-Hodgkin's Lymphoma Medicine & Life Sciences
Mantle-Cell Lymphoma Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Hodgkin Disease Medicine & Life Sciences
B-Cell Lymphoma Medicine & Life Sciences
Follicular Lymphoma Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

ABVD plus rituximab versus ABVD alone for advanced stage, high-risk classical Hodgkin lymphoma: A randomized phase 2 study

Strati, P., Fanale, M. A., Oki, Y., Turturro, F., Fayad, L. E., Bartlett, N. L., Gladstone, D. E., Kasamon, Y. L., Portlock, C. S., Wilson, W. H., Goy, A., Younes, A. & Lee, H. J., Jan 31 2019, In : Haematologica. 104, 2, p. e65-e67

Research output: Contribution to journalLetter

Hodgkin Disease
Rituximab
Marginal Zone B-Cell Lymphoma
Breast
Radiotherapy
Therapeutics
Salvage Therapy

Frontline antibiotic therapy for early-stage Helicobacter pylori-negative gastric MALT lymphoma

Strati, P., Lee, S. T., Teegavarupu, P., Karri, A., Anireddy, S., Hagemeister, F. B., Romaguera, J., Fayad, L. E., Rodriguez, M. A., Samaniego, F., Fowler, N., Westin, J. R., Wang, L., Lee, H. J., Pinnix, C. C., Gunther, J., Dabaja, B. S., Feng, L., Davis, R. E. & Neelapu, S. S., Jun 1 2019, In : American journal of hematology. 94, 6, p. E150-E153

Research output: Contribution to journalLetter

Marginal Zone B-Cell Lymphoma
Helicobacter pylori
Anti-Bacterial Agents
Therapeutics
Familial primary gastric lymphoma